Shares of Heska Corp. (NASDAQ:HSKA) reached a new 52-week high during trading on Tuesday . The company traded as high as $56.43 and last traded at $55.63, with a volume of 99,885 shares. The stock had previously closed at $52.49.

Several equities analysts recently issued reports on HSKA shares. B. Riley restated a “buy” rating and issued a $52.50 price target on shares of Heska Corp. in a research report on Saturday, August 6th. Zacks Investment Research upgraded Heska Corp. from a “hold” rating to a “strong-buy” rating and set a $57.00 price target on the stock in a research report on Friday, August 5th. Gabelli cut Heska Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Sidoti started coverage on Heska Corp. in a research report on Friday, July 1st. They issued a “buy” rating and a $49.00 price target on the stock. Finally, TheStreet upgraded Heska Corp. from a “hold” rating to a “buy” rating in a research report on Wednesday, May 25th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $52.83.

The firm has a market cap of $379.78 million and a P/E ratio of 55.97. The stock has a 50-day moving average of $48.27 and a 200-day moving average of $37.27.

Heska Corp. (NASDAQ:HSKA) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.17. The firm earned $30 million during the quarter, compared to analysts’ expectations of $28.47 million. Heska Corp.’s quarterly revenue was up 25.5% on a year-over-year basis. On average, equities analysts forecast that Heska Corp. will post $1.12 earnings per share for the current fiscal year.

In other news, EVP Steve Asakowicz sold 4,698 shares of the stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $52.55, for a total transaction of $246,879.90. Following the transaction, the executive vice president now owns 12,858 shares of the company’s stock, valued at $675,687.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jason A. Napolitano sold 20,000 shares of the stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $41.00, for a total transaction of $820,000.00. The disclosure for this sale can be found here.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.